ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NUMI Numinus Wellness Inc

0.58
0.00 (0.00%)
22 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Numinus Wellness Inc TSXV:NUMI TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.58 0.57 0.59 0 00:00:00

Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022

31/08/2022 12:30pm

PR Newswire (Canada)


Numinus Wellness (TSXV:NUMI)
Historical Stock Chart


From Nov 2021 to Nov 2024

Click Here for more Numinus Wellness Charts.

VANCOUVER, BC, Aug. 31, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 12-14, 2022. 

Numinus will present on Tuesday, September 13th at 9:00 a.m. ET. To attend, please register here.

For more information about the conference, or to schedule a one-on-one meeting with Numinus' management, please contact your appropriate H.C. Wainwright representative directly, or send an email to KCSA Strategic Communications NuminusIR@kcsa.com.

About Numinus

Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.

Forward-looking statements

Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

Cision View original content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-the-hc-wainwright-24th-annual-global-investment-conference-on-september-12-14-2022-301615370.html

SOURCE Numinus Wellness Inc.

Copyright 2022 Canada NewsWire

1 Year Numinus Wellness Chart

1 Year Numinus Wellness Chart

1 Month Numinus Wellness Chart

1 Month Numinus Wellness Chart

Your Recent History

Delayed Upgrade Clock